|
🐜
|
Randomized study of Lapatinib alone or in combination with trastuzumab in women with ErbB2-positive, trastuzumab-refractory metastatic breast cancer.
12 auth.
K. Blackwell,
H. Burstein,
A. Storniolo,
H. Rugo,
G. Sledge,
M. Koehler,
...
C. Ellis,
M. Casey,
S. Vukelja,
J. Bischoff,
J. Baselga,
J. O’Shaughnessy
|
9 |
2010 |
9
🐜
|
|
🐜
|
CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.
19 auth.
Yan Jin,
Z. Desta,
V. Stearns,
B. Ward,
H. Ho,
Kyung-Hoon Lee,
T. Skaar,
A. Storniolo,
Lang Li,
Adjei Araba,
...
R. Blanchard,
A. Nguyen,
L. Ullmer,
J. Hayden,
S. Lemler,
R. Weinshilboum,
J. Rae,
D. Hayes,
D. Flockhart
|
9 |
2005 |
9
🐜
|
|
🐜
|
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer.
12 auth.
M. Rothenberg,
M. Moore,
M. Cripps,
J. Andersen,
R. Portenoy,
H. Burriss,
...
M. Green,
P. Tarassoff,
T. Brown,
E. Casper,
A. Storniolo,
D. V. Hoff
|
9 |
1996 |
9
🐜
|
|
🐜
|
Overall survival benefit with lapatinib in combination with trastuzumab for patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: final results from the EGF104900 Study.
12 auth.
K. Blackwell,
H. Burstein,
A. Storniolo,
H. Rugo,
G. Sledge,
G. Aktan,
...
C. Ellis,
A. Florance,
S. Vukelja,
J. Bischoff,
J. Baselga,
J. O’Shaughnessy
|
9 |
2012 |
9
🐜
|
|
🐜
|
Parent-of-Origin Specific Allelic Associations Among 106 Genomic Loci for Age at Menarche
198 auth.
J. Perry,
F. Day,
C. Elks,
P. Sulem,
Deborah J. Thompson,
T. Ferreira,
Chunyan He,
D. Chasman,
T. Esko,
G. Thorleifsson,
E. Albrecht,
W. Ang,
T. Corre,
D. Cousminer,
B. Feenstra,
...
N. Franceschini,
A. Ganna,
Andrew D. Johnson,
S. Kjellqvist,
K. Lunetta,
George Mcmahon,
I. Nolte,
L. Paternoster,
E. Porcu,
A. Smith,
L. Stolk,
A. Teumer,
Natalia Tšernikova,
E. Tikkanen,
Sheila Ulivi,
Erin K. Wagner,
N. Amin,
L. Bierut,
Enda M. Byrne,
J. Hottenga,
Daniel L. Koller,
M. Mangino,
T. Pers,
L. Yerges-Armstrong,
J. Zhao,
I. Andrulis,
H. Anton-Culver,
F. Atsma,
S. Bandinelli,
M. Beckmann,
J. Benítez,
C. Blomqvist,
S. Bojesen,
M. Bolla,
B. Bonanni,
H. Brauch,
H. Brenner,
J. Buring,
J. Chang-Claude,
S. Chanock,
Jinhui Chen,
G. Chenevix-Trench,
J. Collée,
F. Couch,
D. Couper,
Andrea D Coveillo,
A. Cox,
K. Czene,
A. d'Adamo,
G. Smith,
I. De Vivo,
E. Demerath,
J. Dennis,
P. Devilee,
A. K. Dieffenbach,
A. Dunning,
G. Eiriksdottir,
J. Eriksson,
P. Fasching,
L. Ferrucci,
D. Flesch-Janys,
H. Flyger,
T. Foroud,
L. Franke,
M. Garcia,
M. García-Closas,
F. Geller,
Eco de Geus,
G. Giles,
D. Gudbjartsson,
V. Gudnason,
P. Guénel,
Sui-Qun Guo,
P. Hall,
U. Hamann,
R. Haring,
C. Hartman,
A. Heath,
A. Hofman,
M. Hooning,
J. Hopper,
F. Hu,
D. Hunter,
D. Karasik,
D. Kiel,
J. Knight,
V. Kosma,
Z. Kutalik,
Sandra Lai,
D. Lambrechts,
A. Lindblom,
R. Mägi,
P. Magnusson,
A. Mannermaa,
N. Martin,
G. Másson,
P. McArdle,
W. McArdle,
M. Melbye,
K. Michailidou,
E. Mihailov,
L. Milani,
R. Milne,
H. Nevanlinna,
P. Neven,
E. Nøhr,
A. Oldehinkel,
B. Oostra,
A. Palotie,
M. Peacock,
N. Pedersen,
P. Peterlongo,
J. Peto,
P. Pharoah,
D. Postma,
A. Pouta,
K. Pylkäs,
P. Radice,
S. Ring,
F. Rivadeneira,
A. Robino,
L. Rose,
A. Rudolph,
V. Salomaa,
S. Sanna,
D. Schlessinger,
M. Schmidt,
M. Southey,
U. Sovio,
M. Stampfer,
D. Stöckl,
A. Storniolo,
N. Timpson,
J. Tyrer,
J. Visser,
P. Vollenweider,
H. Völzke,
G. Waeber,
M. Waldenberger,
H. Wallaschofski,
Qin Wang,
G. Willemsen,
R. Winqvist,
B. Wolffenbuttel,
M. Wright,
D. Boomsma,
M. Econs,
K. Khaw,
R. Loos,
M. McCarthy,
G. Montgomery,
J. Rice,
E. Streeten,
U. Thorsteinsdóttir,
C. V. van Duijn,
B. Alizadeh,
S. Bergmann,
E. Boerwinkle,
H. Boyd,
L. Crisponi,
P. Gasparini,
C. Gieger,
T. Harris,
E. Ingelsson,
M. Järvelin,
P. Kraft,
D. Lawlor,
A. Metspalu,
C. Pennell,
P. Ridker,
H. Snieder,
T. Sørensen,
T. Spector,
D. Strachan,
A. Uitterlinden,
N. Wareham,
E. Widén,
M. Zygmunt,
A. Murray,
D. Easton,
K. Stefánsson,
J. Murabito,
K. Ong
|
8 |
2014 |
8
🐜
|
|
🐜
|
Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: Implication for optimization of breast cancer treatment
14 auth.
S. Borges,
Z. Desta,
Lang Li,
T. Skaar,
B. Ward,
A. Nguyen,
Yan Jin,
A. Storniolo,
D. Nikoloff,
Lin-zhuan Wu,
...
G. Hillman,
D. Hayes,
V. Stearns,
D. Flockhart
|
8 |
2006 |
8
🐜
|
|
🐜
|
TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer.
20 auth.
L. Carey,
H. Rugo,
P. Marcom,
E. Mayer,
F. Esteva,
Cynthia X. Ma,
Minetta C. Liu,
A. Storniolo,
M. Rimawi,
A. Forero-Torres,
...
A. Wolff,
T. Hobday,
A. Ivanova,
W. Chiu,
M. Ferraro,
E. Burrows,
P. Bernard,
K. Hoadley,
C. Perou,
Eric P. Winer
|
8 |
2012 |
8
🐜
|
|
🐢
|
Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer.
13 auth.
N. L. Henry,
F. Azzouz,
Z. Desta,
Lang Li,
A. Nguyen,
S. Lemler,
J. Hayden,
Karineh Tarpinian,
E. Yakim,
D. Flockhart,
...
V. Stearns,
D. Hayes,
A. Storniolo
|
8 |
2012 |
8
🐢
|
|
🦁
|
An investigational new drug treatment program for patients with gemcitabine
A. Storniolo,
N. Enas,
Cheryl A. Brown,
M. Voi,
M. Rothenberg,
R. Schilsky
|
8 |
1999 |
8
🦁
|
|
🐜
|
Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors
16 auth.
N. L. Henry,
J. Giles,
D. Ang,
M. Mohan,
Dina Dadabhoy,
J. Robarge,
J. Hayden,
S. Lemler,
K. Shahverdi,
P. Powers,
...
Lang Li,
D. Flockhart,
V. Stearns,
D. Hayes,
A. Storniolo,
D. Clauw
|
7 |
2008 |
7
🐜
|
|
🦁
|
Chronic myelomonocytic leukemia.
A. Storniolo,
W. Moloney,
D. Rosenthal,
C. Cox,
J. Bennett
|
7 |
1990 |
7
🦁
|
|
🐜
|
Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial.
33 auth.
M. Radovich,
Guanglong Jiang,
B. Hancock,
C. Chitambar,
R. Nanda,
C. Falkson,
F. Lynce,
C. Gallagher,
C. Isaacs,
M. Blaya,
E. Paplomata,
R. Walling,
K. Daily,
R. Mahtani,
M. Thompson,
...
R. Graham,
Maureen E. Cooper,
D. Pavlick,
L. Albacker,
J. Gregg,
Jeffrey P. Solzak,
Yu-Hsiang Chen,
Casey L. Bales,
E. Cantor,
F. Shen,
A. Storniolo,
S. Badve,
T. Ballinger,
Chun-Li Chang,
Y. Zhong,
C. Savran,
K. Miller,
B. Schneider
|
7 |
2020 |
7
🐜
|
